
Lumbar fusion: rhBMP-2 reduces rate of fusion failure and reoperation

Lumbar fusion: rhBMP-2 reduces rate of fusion failure and reoperation
Recombinant human bone morphogenetic protein-2 versus autogenous iliac crest bone graft for lumbar fusion: a meta-analysis of ten randomized controlled trials
Arch Orthop Trauma Surg. 2012 Dec;132(12):1725-40. doi: 10.1007/s00402-012-1607-3. Epub 2012 Sep 1Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
This meta-analysis included 10 randomized controlled trials comparing recombinant human bone morphogenetic protein-2 (rhBMP-2) and iliac crest bone graft (ICBG) in patients receiving lumbar fusion. The results from the analysis indicated that the rate of fusion failure was significantly lower in the rhBMP-2 group than in the ICBG group at 6, 12, and 24 months. The rhBMP-2 group was also superior t...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!

Learn about our AI Driven
High Impact Search Feature

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.